In a surprising turn of events, U.S. President Donald Trump has stated that he might reconsider the United States’ decision to leave the World Health Organization (WHO). Speaking at a rally in Las Vegas on January 25, Trump suggested the U.S. could rejoin the global health agency under certain conditions, emphasizing the need for reforms.
“Maybe we would consider doing it again. They would have to clean it up,” Trump told his supporters. His comments come just days after officially initiating the U.S. withdrawal from the WHO, citing the organization’s alleged failures in handling the COVID-19 pandemic and other global health crises.
U.S. Exit Timeline and Financial Stakes
The United States is set to officially exit the WHO on January 22, 2026, marking a significant shift in its involvement with global health governance. Trump announced this decision earlier in the week, shortly after beginning his second term in office.
The U.S. has been the WHO’s largest financial contributor, accounting for approximately 18% of its total funding. In comparison, the WHO’s two-year budget for 2024-2025 stands at $6.8 billion. Trump criticized the financial imbalance, noting that the U.S. pays significantly more than countries like China despite its smaller population.
Saudi Investment and Economic Implications
In addition to his comments on the WHO, Trump revealed plans to secure a $1 trillion investment from Saudi Arabia, significantly higher than the $600 billion already pledged. Saudi Crown Prince Mohammed bin Salman reportedly conveyed the kingdom’s intent to enhance trade and investment with the U.S. over the next four years.
The proposed investments align with Trump’s broader strategy to strengthen the U.S. economy and global influence. However, critics argue that the administration’s actions, including the WHO withdrawal, could undermine America’s leadership role in addressing global health challenges.
What’s Next?
Trump’s openness to rejoining the WHO signals a potential shift in policy, but the conditions for re-entry remain unclear. As the 2026 exit deadline approaches, the decision will likely depend on whether the WHO addresses Trump’s concerns and implements the reforms he deems necessary.
For now, the possibility of renewed U.S. engagement with the WHO raises critical questions about the future of global health collaboration. Will Trump’s stance encourage reforms, or could it further isolate the U.S. from international efforts to combat health crises?
Stay updated on this developing story as we analyze its global implications.
